RITE AID · 2 days ago
Sr Analyst, Payer Compliance
Maximize your interview chances
MedicalPharmaceutical
Insider Connection @RITE AID
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Manage Internal Claim Review process through continual maintenance of database, drug product list, and drug product error parameters.
Analyze pre-dispensed prescription claim level data, build queries, maintain analyses, models, and dashboard to improve pharmacy claims accuracy to reduce potential audit chargebacks.
Analyze and Identify patterns of post-dispensed prescription billing errors through analysis of prescription claim data, previous PBM audit findings, and drug product research. Effectively compile and communicate findings to leadership or stakeholders verbally, visually, and in writing.
Collaborate with internal business units to propose and help put in place system enhancements to reduce prescription billing errors.
Work with field leaders, audit companies, and PBM’s to proactively remediate and resolve audit issues as it pertains to claim billing, audits, and the drug dispensing process.
Support special projects/initiatives, produce routine and ad hoc reports to compile audit statistics to aid in management decision making.
Adaptable, open to change, and able to work in ambiguous situations and respond to new information or unexpected circumstances.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor Degree in Business, Finance, or Information Technology
Advanced Microsoft Excel experience including VBA and Macro code
5 years of experience in Financial or Operational Analysis
5 years of experience in PBM, Healthcare or Retail Pharmacy
Preferred
Experience with a computer programming language such as xml, SQL, HTML or PHP
Tableau experience
Company
RITE AID
Rite Aid is a full-service pharmacy company that offers prescription medications, over-the-counter drugs, and health and wellness products.
Funding
Current Stage
Public CompanyTotal Funding
$3.65B2023-10-16Debt Financing· $3.45B
2022-11-23Post Ipo Debt· $200M
2019-05-17Post Ipo Equity· $3.45M
Leadership Team
Recent News
Business Insider
2024-11-07
Company data provided by crunchbase